Braftovi received accelerated approval with Erbitux and mFOLFOX6 for metastatic colorectal cancer with a BRAF V600E mutation.

Mainz Biomed has announced a partnership with Quest Diagnostics to support the commercialisation of its NextGen colorectal ...

A non-invasive, easy-to-use test, like the Cologuard test, is a simple and effective way to screen for colorectal cancer. In ...

(RTTNews) - Mainz Biomed N.V. (MYNZ), Thursday announced a collaboration with Quest Diagnostics Inc. (DGX) to commercialize the former's NextGen screening test for colorectal cancer, called ColoAlert ...

Quest to Support Mainz Biomed’s ReconAAsense FDA Study and Has Option to Commercialize Test Kit Assuming FDA ApprovalBERKELEY ...

Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test Quest to Support Mainz Biomed’s ReconAAsense FDA Study and Has ...

Bowel cancer, also known as colorectal cancer, is an aggressive cancer with a high incidence in developed countries.

Intervention participants were more likely to complete screening and to have detection of advanced colorectal neoplasia.

A healthcare firm, Codix Group, has received World Health Organisation approval to package a prequalified Rapid Diagnostic test kit locally. In a statement, Codix Group, a subsidiary of Colexa ...

TOPEKA, Kan. (WIBW) - Many people shy away from a key cancer screening because it can involve what many feel is a disruptive, uncomfortable prep. With colon cancer rates rising, advocates hope a ...

There is a new option available for cervical cancer screening for women 30 years of age. NYPD chief of detectives says Luigi Mangione was never a client of UnitedHealthcare Golden Globe 2025 nomin ...

While bowel cancer – or colorectal cancer – has traditionally been more common in people over the age of 50, cases in the ...